bf/NASDAQ:CGEM_icon.png

NASDAQ:CGEM

Cullinan Oncology

  • Stock

USD

Last Close

7.35

06/11 21:01

Market Cap

923.88M

Beta: 0.10

Volume Today

456.26K

Avg: 224.28K

PE Ratio

−4.92

PFCF: −5.42

OverviewFinancialsAPI

    Description

    Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its p...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -6-4-22462019-06-292020-06-292021-11-092023-11-082024-11-13

    Revenue (Estimate*)

    -40M-20M20M40M2019-06-292020-06-292021-11-092023-11-082024-11-13

    *Estimate based on analyst consensus